Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
batimastat | disintegrin and metalloproteinase domain-containing protein 28 | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Hamman-Rich syndrome[MeSHID:D011658] |
NA | experimental | unknown |
batimastat | a disintegrin and metalloproteinase with thrombospondin motifs 5 | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Hamman-Rich syndrome[MeSHID:D011658] |
NA | experimental | unknown |
batimastat | macrophage metalloelastase | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Hamman-Rich syndrome[MeSHID:D011658] |
NA | experimental | unknown |
batimastat | matrix metalloproteinase-16 | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Hamman-Rich syndrome[MeSHID:D011658] |
NA | experimental | unknown |
batimastat | matrix metalloproteinase-3 | NA | Patented-recorded target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Hamman-Rich syndrome[MeSHID:D011658] |
1.06 | preclinical | inhibitor |
batimastat | neutrophil collagenase | small molecule | NA | drugbank | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Hamman-Rich syndrome[MeSHID:D011658] |
NA | experimental | unknown |
click here to return to the previous page |